US News Sanofi invests 400 million in a new vaccine plant (in Singapore)
COVID-19: Start of production of the first vaccines Made in France
The production of vaccines in France against the CVIV-19 must start Wednesday, with a French subcontractor Delpharm, have we learned on Monday to the Ministry French Economy and Finance, confirming press information. "Production must begin this week, in this case Wednesday at Delpharm, in its Saint-Rémy-sur-Avre plant (Eure-et-Loir, northwestern France), for (the account of the German laboratory account ) Biontech ", a partner of the American Pfizer, said Bercy to AFP.
The French Pharmaceutical Giant will invest 400 million euros to build in the coming years a vaccine plant in Singapore, intended to feed the Asian market , he announced Monday.
"Sanofi will invest 400 million euros over five years in the creation of a single vaccine production site in Singapore," said the group in a statement without further details on the type of vaccines. will be produced.
The factory, whose construction must begin from this summer, will be operational in 2026 and will have the specificity of producing three or four vaccines at a time, while the current Sanofi sites each focus on a single product.
Covid-19: Olivier Véran evokes vaccination records while the situation remains tense at
© SIPA The Minister of Health stated that the country had made a record number of injections on Thursday with more than 400,000 doses of inoculated vaccine. The acceleration of the campaign must continue at a time when hospitals are still under strong pressure. The Minister of Health stated that the country had made a record number of injections on Thursday with more than 400,000 doses of inoculated vaccine.
"The factory will also have the flexibility necessary to exploit multiple technological platforms for the production of vaccines using different cell categories," said Sanofi.third vaccine factory project in one year
"This modularity and flexibility will allow + prioritize + the production of a specific vaccine in faster deadlines, depending on public health issues," he detailed .
This is the third vaccine project announced by the Group for a year after an investment in France, last year, then a site in Canada here are two weeks.Read also:
These investments intervene at the time the group was exceeded by several competitors, such as Pfizer and Astrazeneca, in the race for anti-Covid vaccines. He has two current projects, which will not succeed in a launch before the end of the year at the earliest.
Sanofi is also the subject of criticism of its unions for pursuing research job cuts, but the Group regularly stressed that they did not concern vaccines.
DRC: Launch Ceremony of the Vaccination Campaign .
© Arnd Nimani AFP / Archivos The launch of the Vovid-19 vaccination campaign took place on Monday, April 19, in the DRC. The Democratic Republic of Congo (DRC), launched, this Monday, April 19, in Kinshasa, the Vovid-19 vaccination campaign. Despite polemics and controversies that the AstraZeneca vaccine has sparked around the world and the media, the Congolese authorities have selected it for the campaign, after a first postponement, as a precaution.